Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611
This examiner grants 43% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18013508 | GSK3 INHIBITOR-LOADED NANO FORMULATIONS AS A CANCER IMMUNOTHERAPEUTIC | Final Rejection | The Regents of the University of California |
| 19276575 | LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS | Final Rejection | Definium Therapeutics US, Inc. |
| 17972972 | PLASTICIZERS TO IMPROVE RELEASE PERFORMANCE OF AMORPHOUS SOLID DISPERSIONS | Non-Final OA | Purdue Research Foundation |
| 18050593 | COSMETIC COMPOSITIONS COMPRISING HIGH AMOUNTS OF RETINOL | Final Rejection | L'OREAL |
| 19067153 | TOPICAL ADMINISTRATION TO THE ORAL CAVITY | Final Rejection | CMPD Licensing, LLC |
| 18041618 | NANOPARTICULATE SYSTEM FOR TREATING ORAL CANCER | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 18741947 | HAIR VOLUMIZING SYSTEM USING CHITOSAN COMPLEX FOR LONG-LASTING EFFECT | Non-Final OA | Henkel AG & Co. KGaA |
| 17992102 | Oral Care Compositions and Methods for the Same | Final Rejection | Colgate-Palmolive Company |
| 18018205 | TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS | Non-Final OA | L.E.A.F. HOLDINGS GROUP LLC |
| 18709033 | ACTIVE METAL MICROSPHERES AND COMPOSITE EMBOLIC AGENT BASED ON SAME | Non-Final OA | CHONGQING BAIMAITENGSHI PHARMACEUTICAL TECHNOLOGY CO., LTD |
| 18681625 | METHOD FOR THE PASSIVATION OF SURGICAL IMPLANTS COMPRISING TITANIUM, AND SURGICAL IMPLANT OBTAINED | Non-Final OA | IQC2010 S.L. |
| 18423812 | AMORPHOUS NANO-MOLECULAR AGGREGATE COMPOSED OF ORGANIC MATERIAL, INORGANIC MATERIAL, OR SALT THEREOF, AND METHOD FOR PREPARING SAME | Non-Final OA | SCAI THERAPEUTICS CO., LTD. |
| 16883625 | SKIN PERMEATION ENHANCING COMPOSITION | Final Rejection | Professional Compounding Centers of America, Inc. |
| 17604227 | Compositions and Methods of Manufacturing Star Polymers for Ligand Display and/or Drug Delivery | Final Rejection | The United States of America, as represented by the Secretary, Department of Health and Human Servic |
| 17294677 | OPACIFIER CONCENTRATE AND ITS USE TO MODIFY THE APPEARANCE AND/OR INCREASE OPACITY AND/OR WHITENESS OF AN AQUEOUS COMPOSITION | Non-Final OA | SPECIALTY OPERATIONS FRANCE |
| 18084069 | TESTIS-TARGETED LYCOPENE (LYC)/ZIF-90 NANOCOMPOSITE AND PREPARATION METHOD AND USE THEREOF | Non-Final OA | NORTHEAST AGRICULTURAL UNIVERSITY |
| 17909696 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS | Final Rejection | Endolytix Technology, Inc. |
| 17625825 | BIOPOLYMER-BASED MENISCUS IMPLANT | Non-Final OA | Shu-Tung and Alice Li Foundation Inc. |
| 17269863 | NOVEL USE OF PHYTOSTENONE | Non-Final OA | Daisankasei Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy